课题基金 / 基金详情

Y 90 CHIMERIC T84 66 ANTI CEA ANTIBODY IN ADVANCE CEA PRODUCING MALIG

Y 90 CHIMERIC T84 66 ANTI CEA ANTIBODY IN ADVANCE CEA PRODUCING MALIG
Y 90 嵌合 T84 66 抗 CEA 抗体提前 CEA 产生 MALIG
批准号：
6421118
负责人：
JEFFREY Y WONG
金额：
$15.58万
依托单位：
UNIVERSITY OF SOUTHERN CALIFORNIA
依托单位国家：
美国
项目类别：
财政年份：
2000
资助国家：
美国
项目状态：
已结题
起止时间：
2000-12-01 至 2001-11-30
来源：
https://reporter.nih.gov/project-details/6421118
关键词：
abdomen neoplasm adult human (21+) antitumor antibody carcinoembryonal antigen chimeric proteins clinical research clinical trial phase I combination cancer therapy drug screening /evaluation human subject human therapy evaluation immunoconjugates injection /infusion neoplasm /cancer immunotherapy neoplasm /cancer radiation therapy pharmacokinetics yttrium

项目成果

JEFFREY Y WONG的其他基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anti-CD25 Radioimmunotherapy and Total Marrow Irradiation for Treatment of Relapsed and Refractory Acute Leukemia
Anti-CD25 Radioimmunotherapy and Total Marrow Irradiation for Treatment of Relapsed and Refractory Acute Leukemia
A PHASE I STUDY OF A COMBINATION OF YTTRIUM-90 LABELED HUMANIZED ANTI-CEA M5A
A PHASE I TRIAL OF RADIOIMMUNOTHERAPY (Y-90 CT8466), GEMCITABINE AND HEPATIC